Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,290.00
-30.00 (-0.69%)
Apr 29, 2026, 3:30 PM KST

Yuyu Pharma Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
29,09141,83230,60525,83950,263
Upgrade
Trading Asset Securities
3,614817.271,7494,939-
Upgrade
Cash & Short-Term Investments
32,70542,65032,35430,77850,263
Upgrade
Cash Growth
-23.32%31.82%5.12%-38.77%145.15%
Upgrade
Accounts Receivable
18,55317,66220,80121,94019,528
Upgrade
Other Receivables
1,3292,0693,6532,8763,265
Upgrade
Receivables
19,88219,73124,45524,81622,793
Upgrade
Inventory
42,22138,62844,15239,83225,225
Upgrade
Prepaid Expenses
940.94327.71341.03238.84115.08
Upgrade
Other Current Assets
1,166611.32294.62692.94491.06
Upgrade
Total Current Assets
96,914101,947101,59796,35898,888
Upgrade
Property, Plant & Equipment
93,45789,98781,40381,37180,341
Upgrade
Long-Term Investments
10,2178,6266,8675,9445,712
Upgrade
Goodwill
153.77153.77503.2250.8350.83
Upgrade
Other Intangible Assets
2,6802,9773,7643,6664,087
Upgrade
Long-Term Accounts Receivable
---0493.76345.28
Upgrade
Long-Term Deferred Tax Assets
1,028909.48---
Upgrade
Other Long-Term Assets
2,6732,9884,0796,8263,561
Upgrade
Total Assets
207,223207,687198,214195,205192,985
Upgrade
Accounts Payable
9,3779,47510,95215,8418,982
Upgrade
Accrued Expenses
1,4161,4941,5041,6131,553
Upgrade
Short-Term Debt
27,19131,18624,48236,1648,200
Upgrade
Current Portion of Long-Term Debt
33.321,475448.73718.281,812
Upgrade
Current Portion of Leases
441.66581.1455.55542.86414.94
Upgrade
Current Income Taxes Payable
780.61,043574.8297.04219.32
Upgrade
Other Current Liabilities
19,70819,22611,5589,1408,832
Upgrade
Total Current Liabilities
58,94864,48049,97564,31630,015
Upgrade
Long-Term Debt
-33.3213,6401,60028,456
Upgrade
Long-Term Leases
256.52369.17380.92250.96282.81
Upgrade
Pension & Post-Retirement Benefits
3,1032,8592,2861,7322,491
Upgrade
Long-Term Deferred Tax Liabilities
3,5814,0944,3603,6902,897
Upgrade
Other Long-Term Liabilities
791.74788.347,215242.12158.07
Upgrade
Total Liabilities
66,67972,62477,85871,83164,300
Upgrade
Common Stock
17,60917,60917,60917,60917,609
Upgrade
Additional Paid-In Capital
64,68464,98165,07558,80358,803
Upgrade
Retained Earnings
32,49825,78920,17131,39636,540
Upgrade
Treasury Stock
-7,788-5,791-5,791-6,156-4,371
Upgrade
Comprehensive Income & Other
20,03620,05012,53112,57213,107
Upgrade
Total Common Equity
127,039122,639109,595114,224121,689
Upgrade
Minority Interest
10,9139,8318,1686,5584,404
Upgrade
Shareholders' Equity
140,544135,063120,356123,374128,685
Upgrade
Total Liabilities & Equity
207,223207,687198,214195,205192,985
Upgrade
Total Debt
27,92333,64439,40739,27639,166
Upgrade
Net Cash (Debt)
4,7839,005-7,053-8,49911,097
Upgrade
Net Cash Growth
-46.89%---1907.08%
Upgrade
Net Cash Per Share
282.12529.76-433.55-512.57695.34
Upgrade
Filing Date Shares Outstanding
16.1516.1816.1816.3516.66
Upgrade
Total Common Shares Outstanding
16.1516.1816.1816.3516.66
Upgrade
Working Capital
37,96737,46851,62132,04268,873
Upgrade
Book Value Per Share
7864.407578.446772.386985.777306.09
Upgrade
Tangible Book Value
124,205119,509105,327110,506117,551
Upgrade
Tangible Book Value Per Share
7688.947384.996508.666758.427057.65
Upgrade
Land
39,96239,96230,38030,38030,380
Upgrade
Buildings
54,56153,19253,39752,13848,966
Upgrade
Machinery
44,57842,21739,22937,06733,334
Upgrade
Construction In Progress
3,686385.8259.361,3333,454
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.